Texas Capital Bank Wealth Management Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$258K Buy
7,016
+2,095
+43% +$99.3K 0.02% 303
2025
Q4
$250K Buy
+4,921
New +$252K 0.01% 283
2024
Q4
Sell
-5,771
Closed -$687K 193
2024
Q3
$687K Sell
5,771
-5,609
-49% -$748K 0.07% 101
2024
Q2
$1.62M Buy
+11,380
New +$1.51M 0.17% 58

Other funds holding NVO

Texas Capital Bank Wealth Management Services's NVO Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services increased its Novo Nordisk (NVO) stake by 43% in Q1 2026, buying an estimated $99.3K and bringing the position to 7,016 shares worth $258K. The position accounts for 0.02% of the portfolio, ranked #303.

Texas Capital Bank Wealth Management Services first reported a position in NVO in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.62M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 7,016 shares of Novo Nordisk worth $258K as of Q1 2026.
  • Texas Capital Bank Wealth Management Services bought 2,095 Novo Nordisk shares in Q1 2026, an estimated $99.3K.
  • Novo Nordisk made up 0.02% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #303 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Novo Nordisk in Q2 2024 and has held it in 4 quarters since.
  • Texas Capital Bank Wealth Management Services's Novo Nordisk position peaked at $1.62M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.